作者
Jamey P Weichert, Paul A Clark, Irawati K Kandela, Abram M Vaccaro, William Clarke, Marc A Longino, Anatoly N Pinchuk, Mohammed Farhoud, Kyle I Swanson, John M Floberg, Joseph Grudzinski, Benjamin Titz, Anne M Traynor, Hong-En Chen, Lance T Hall, Christopher J Pazoles, Perry J Pickhardt, John S Kuo
发表日期
2014/6/11
期刊
Science translational medicine
卷号
6
期号
240
页码范围
240ra75-240ra75
出版商
American Association for the Advancement of Science
简介
Many solid tumors contain an overabundance of phospholipid ethers relative to normal cells. Capitalizing on this difference, we created cancer-targeted alkylphosphocholine (APC) analogs through structure-activity analyses. Depending on the iodine isotope used, radioiodinated APC analog CLR1404 was used as either a positron emission tomography (PET) imaging (124I) or molecular radiotherapeutic (131I) agent. CLR1404 analogs displayed prolonged tumor-selective retention in 55 in vivo rodent and human cancer and cancer stem cell models. 131I-CLR1404 also displayed efficacy (tumor growth suppression and survival extension) in a wide range of human tumor xenograft models. Human PET/CT (computed tomography) and SPECT (single-photon emission computed tomography)/CT imaging in advanced-cancer patients with 124I-CLR1404 or 131I-CLR1404, respectively, demonstrated selective uptake …
引用总数
201420152016201720182019202020212022202320243812138161516161210
学术搜索中的文章
JP Weichert, PA Clark, IK Kandela, AM Vaccaro… - Science translational medicine, 2014